Background The BRAF V600E mutation is the most common genetic alteration in papillary
thyroid carcinoma (PTC). The aim of this study is to analyze the clinicopathologic correlations …

Background The purpose of this study was to evaluate the potential relationship between
Hashimoto's thyroiditis and BRAF V600E mutation status in patients with papillary thyroid …

… in thyroid cancer cells, our findings suggest an interplay between BRAF V600E mutation and
p27 Kip1 underexpression. Further in vitro experiments are needed to clarify these possible …

… In the present study, BRAFV600E mutation was present in 85% (34/40) of patients with
PTC. This frequency is a little higher than that of the previous studies. Possible reasons for this …

BRAFV600E mutation, BRAF-activated long non-coding RNA and miR-9 expression in
papillary thyroid carcinoma, and their association with clinicopathological features | World …

… The BRAF V600E mutation is associated with papillary thyroid carcinoma (PTC). We conducted
a systemic review and meta-analysis to evaluate the diagnostic utility of the BRAF V600E …

… an important oncogene in the development of papillary thyroid carcinoma (PTC) and has been
… the BRAFV600E mutation is a prognostic marker in patients with solitary papillary thyroid …

… differentiated carcinoma cells are generated from thyroid cancer stem cells. A thyroid cancer
… can generate anaplastic or papillary carcinoma cells but not follicular carcinoma cells, since …

… Objective To investigate the association of concomitant BRAFV600E mutation with central
lymph node metastases in papillary thyroid carcinoma (PTC). Methods The clinicopathological …

… BRAFV600E mutation in Chinese population with papillary … the incidence of thyroid cancer
ranks ninth among all cancers. … to papillary thyroid cancer (PTC), in particular papillary thyroid …